Ligand Reports Third Quarter 2022 Financial Results
Go back to Ligand Reports Third Quarter 2022 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 294.60 +5.78 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $288.82 | 52 Week High | $139.79 | |||
| Open | $287.61 | 52 Week Low | $82.07 | |||
| Day High | $295.19 | P/E | 685.12 | |||
| Day Low | $287.20 | EPS | $0.43 | |||
| Volume | 197,209 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 1,000,000 | |||||
